WASHINGTON (CN) - Some Hospira Carpuject pre-filled syringe cartridges contain extra medication, which may produce an overdose, according to a Food and Drug Administration press release. Pharmacies ...

ISMP has long endorsed the use of unit dose syringes of injectable drugs, including Carpujects, as a safe practice. If Carpuject cartridges are stocked in patient care units, to ensure proper use ISMP ...

The FDA announced a recall of Naloxone on Monday after the antidote’s manufacturer flagged a potential issue with the syringe plunger. Hospira Inc., which is a Pfizer company, said the potential ...

Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe system ...

UNDATED - Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe ...

The batch was distributed between August 14, 2018 and September 5, 2018. Two lots of naloxone hydrochloride injections, USP have been recalled by Hospira, Inc., due to concerns regarding the presence ...

The FDA has announced a nationwide recall of the overdose antidote drug Naloxone. According to the FDA website, Hospira, Inc. is voluntarily recalling lots 72680LL and 76510LL of Naloxone ...

FDA Recall Alert Two lots of naloxone hydrochloride injections, USP have been recalled by Hospira, Inc., due to concerns regarding the presence of particulates on the syringe plunger. Two lots of ...

Abbott Laboratories signed a definitive agreement to acquire parenteral products businesses from Sanofi Pharmaceuticals Inc. for $200 million. Abbott said it will receive worldwide rights to prefilled ...

For the third time in six months, Pfizer (PFE) is having difficulty manufacturing certain prefilled syringes of opioid painkillers — and the ongoing supply problems are upsetting hospitals around the ...

The survey was completed by 540 nurses, predominantly staff-level registered nurses (78%) and, to a much lesser extent, nurse managers (8%) and nurse educators (8%). Most participating nurses (87%) ...